The present invention relates to chemokine receptor binding compounds, pharmaceutical compositions and their use. More specifically, the present invention relates to modulators of chemokine receptor activity, preferably modulators of CCR5. These compounds demonstrate protective effects against infection of target cells by a human immunodeficiency virus (HIV).
申请公布号
CA2548393(A1)
申请公布日期
2005.06.30
申请号
CA20042548393
申请日期
2004.12.13
申请人
ANORMED INC.
发明人
BOGUCKI, DAVID;YANG, WEN;LANGILLE, JONATHAN;SKERLJ, RENATO;METZ, MARKUS;BOURQUE, ELYSE;ZHOU, YUANXI;DI FLURI, MARIA ROSARIA;LI, TONG-SHUANG;BRIDGER, GARY J.;NAN, SIQIAO